Literature DB >> 15612829

Reconciliation of economic concerns and health policy: illustration of an equity adjustment procedure using proportional shortfall.

Elly A Stolk1, Gijs van Donselaar, Werner B F Brouwer, Jan J V Busschbach.   

Abstract

Economic evaluations have become an important and much used tool in aiding decision makers in deciding on reimbursement or implementation of new healthcare technologies. Nevertheless, the impact of economic evaluations on reimbursement decisions has been modest; results of economic evaluations do not have a good record in predicting funding decisions. This is usually explained in terms of fairness; there is increasing awareness that valuations of QALYs may differ when the QALYs accrue to different patients. The problem, however, is that these equity concerns often remain implicit, and therefore frustrate explicitness and transparency in evidence-based decision making. It has been suggested that a so-called equity adjustment procedure may (partially) solve this problem. Typically this would involve the application of so-called equity weights, which can be used to recalculate the value of QALY gains for different patients. This paper explores such an equity adjustment procedure, using the equity concept of proportional shortfall. Proportional shortfall assumes that measurement of inequalities in health should concentrate on the fraction of QALYs that people lose relative to their remaining life expectancy, and not on the absolute number of QALYs lost or gained. It is the ratio of QALYs lost over the QALYs remaining. This equity concept combines elements of two popular but conflicting notions of equity: fair innings and severity-of-illness. We applied the concept of proportional shortfall to ten conditions and tentatively explored how an equity adjustment procedure using proportional shortfall might affect priority setting. Our equity adjustment procedure lowered the cost-effectiveness threshold when a condition was relatively mild. Because the proportional shortfall caused by the ten conditions differed considerably, the equity-adjustment procedure discriminated strongly between the ten conditions, and this experiment provided a good opportunity to explore the impact of equity adjustment for healthcare reimbursement decisions. In conclusion, our results suggest that equity can be measured and that integration of equity concerns into an economic evaluation improves the fit between economic models and reimbursement decisions. It is recommended that cost-effectiveness driven health policy systems consider equity adjustments.

Entities:  

Mesh:

Year:  2004        PMID: 15612829     DOI: 10.2165/00019053-200422170-00001

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


  17 in total

1.  Equity in health: the importance of different health streams.

Authors:  P A Dolan; J A Olsen
Journal:  J Health Econ       Date:  2001-09       Impact factor: 3.883

2.  Should we aggregate relative or absolute changes in QALYs?

Authors:  M Johannesson
Journal:  Health Econ       Date:  2001-10       Impact factor: 3.046

3.  The 'fair innings argument' deserves a fairer hearing! Comments by Alan Williams on Nord and Johannesson.

Authors:  A Williams
Journal:  Health Econ       Date:  2001-10       Impact factor: 3.046

4.  Cost-effectiveness analysis and the consistency of decision making: evidence from pharmaceutical reimbursement in australia (1991 to 1996).

Authors:  B George; A Harris; A Mitchell
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

5.  Equity weights in the allocation of health care: the rank-dependent QALY model.

Authors:  Han Bleichrodt; Enrico Diecidue; John Quiggin
Journal:  J Health Econ       Date:  2004-01       Impact factor: 3.883

6.  QALYs and the equity-efficiency trade-off.

Authors:  A Wagstaff
Journal:  J Health Econ       Date:  1991-05       Impact factor: 3.883

7.  Public views on health care rationing: a group discussion study.

Authors:  R Cookson; P Dolan
Journal:  Health Policy       Date:  1999-10       Impact factor: 2.980

Review 8.  Intergenerational equity: an exploration of the 'fair innings' argument.

Authors:  A Williams
Journal:  Health Econ       Date:  1997 Mar-Apr       Impact factor: 3.046

9.  Incorporating societal concerns for fairness in numerical valuations of health programmes.

Authors:  E Nord; J L Pinto; J Richardson; P Menzel; P Ubel
Journal:  Health Econ       Date:  1999-02       Impact factor: 3.046

Review 10.  The person-trade-off approach to valuing health care programs.

Authors:  E Nord
Journal:  Med Decis Making       Date:  1995 Jul-Sep       Impact factor: 2.583

View more
  32 in total

Review 1.  Introducing economic evaluation as a policy tool in Korea: will decision makers get quality information? : a critical review of published Korean economic evaluations.

Authors:  Kun-Sei Lee; Werner B F Brouwer; Sang-Il Lee; Hye-Won Koo
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

2.  The value of thinly spread QALYs.

Authors:  Duncan Mortimer
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

3.  The new myth: the social value of the QALY.

Authors:  Werner Brouwer; Job van Exel; Rachel Baker; Cam Donaldson
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

Review 4.  Economic Evaluations of First-Line Chemotherapy Regimens for Pancreatic Cancer: A Critical Review.

Authors:  Mahdi Gharaibeh; J Lyle Bootman; Ali McBride; Jennifer Martin; Ivo Abraham
Journal:  Pharmacoeconomics       Date:  2017-01       Impact factor: 4.981

5.  Are some QALYs more equal than others?

Authors:  E J van de Wetering; N J A van Exel; J M Rose; R J Hoefman; W B F Brouwer
Journal:  Eur J Health Econ       Date:  2014-12-06

6.  Does the use of the proportional shortfall help align the prioritisation of health services with public preferences?

Authors:  Jeff Richardson; Angelo Iezzi; Aimee Maxwell; Gang Chen
Journal:  Eur J Health Econ       Date:  2017-08-11

7.  Some inconsistencies in NICE's consideration of social values.

Authors:  Mike Paulden; James F O'Mahony; Anthony J Culyer; Christopher McCabe
Journal:  Pharmacoeconomics       Date:  2014-11       Impact factor: 4.981

8.  Criteria for Drug Reimbursement Decision-Making: An Emerging Public Health Challenge in Bulgaria.

Authors:  Georgi Iskrov; Rumen Stefanov
Journal:  Balkan Med J       Date:  2016-01-01       Impact factor: 2.021

9.  A cost-based equity weight for use in the economic evaluation of primary health care interventions: case study of the Australian Indigenous population.

Authors:  Katherine S Ong; Margaret Kelaher; Ian Anderson; Rob Carter
Journal:  Int J Equity Health       Date:  2009-10-07

10.  Cost-effectiveness of the diabetes care protocol, a multifaceted computerized decision support diabetes management intervention that reduces cardiovascular risk.

Authors:  Frits G W Cleveringa; Paco M J Welsing; Maureen van den Donk; Kees J Gorter; Louis W Niessen; Guy E H M Rutten; William K Redekop
Journal:  Diabetes Care       Date:  2009-11-23       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.